The ARID1B phenotype: What we have learned so far

Gijs W E Santen, Jill Clayton-Smith, Miho Adachi-Fukuda, Adila AlKindy, Anwar Baban, Katherine Berry, Natalie Canham, Amanda Collins, Krystyna Chrzanowska, Alice Gardham, Denise Horn, Mitsuhiro Kato, Tomoki Kosho, Malgorzata Krajewska-Walasek, Nancy Kramer, Saskia Maas, Isabelle Maystadt, Grazia Mancini, Shane McKee, Jeff MilunskiNoriko Miyake, Seiji Mizuno, Hirofumi Ohashi, Nobuhiko Okamoto, Stephen Robertson, Gabriela Soares, Saori Tanabe, Catherine Vincent-Delorme, Bert de Vries, Dagmar Wieczorek, Louise Wilson

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Evidence is now accumulating from a number of sequencing studies that ARID1B not only appears to be one of the most frequently mutated intellectual disability (ID) genes, but that the range of phenotypes caused by ARID1B mutations seems to be extremely wide. Thus, it is one of the most interesting ID genes identified so far in the exome sequencing era. In this article, we review the literature surrounding ARID1B and attempt to delineate the ARID1B phenotype. The vast majority of published ARID1B patients have been ascertained through studies of Coffin-Siris syndrome (CSS), which leads to bias when documenting the frequencies of phenotypic features. Additional observations of those individuals ascertained through exome sequencing studies helps in delineation of the broader clinical phenotype. We are currently establishing an ARID1B consortium, aimed at collecting ARID1B patients identified through genome-wide sequencing strategies. We hope that this endeavor will eventually lead to a more comprehensive view of the ARID1B phenotype.

Original languageEnglish
Pages (from-to)276-289
Number of pages14
JournalAmerican Journal of Medical Genetics, Part C: Seminars in Medical Genetics
Volume166
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Exome
Phenotype
Intellectual Disability
Genes
Genome
Mutation
Coffin-Siris syndrome

Keywords

  • ARID1B
  • Coffin-siris syndrome
  • Review

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics
  • Medicine(all)

Cite this

Santen, G. W. E., Clayton-Smith, J., Adachi-Fukuda, M., AlKindy, A., Baban, A., Berry, K., ... Wilson, L. (2014). The ARID1B phenotype: What we have learned so far. American Journal of Medical Genetics, Part C: Seminars in Medical Genetics, 166(3), 276-289. https://doi.org/10.1002/ajmg.c.31414

The ARID1B phenotype : What we have learned so far. / Santen, Gijs W E; Clayton-Smith, Jill; Adachi-Fukuda, Miho; AlKindy, Adila; Baban, Anwar; Berry, Katherine; Canham, Natalie; Collins, Amanda; Chrzanowska, Krystyna; Gardham, Alice; Horn, Denise; Kato, Mitsuhiro; Kosho, Tomoki; Krajewska-Walasek, Malgorzata; Kramer, Nancy; Maas, Saskia; Maystadt, Isabelle; Mancini, Grazia; McKee, Shane; Milunski, Jeff; Miyake, Noriko; Mizuno, Seiji; Ohashi, Hirofumi; Okamoto, Nobuhiko; Robertson, Stephen; Soares, Gabriela; Tanabe, Saori; Vincent-Delorme, Catherine; de Vries, Bert; Wieczorek, Dagmar; Wilson, Louise.

In: American Journal of Medical Genetics, Part C: Seminars in Medical Genetics, Vol. 166, No. 3, 2014, p. 276-289.

Research output: Contribution to journalArticle

Santen, GWE, Clayton-Smith, J, Adachi-Fukuda, M, AlKindy, A, Baban, A, Berry, K, Canham, N, Collins, A, Chrzanowska, K, Gardham, A, Horn, D, Kato, M, Kosho, T, Krajewska-Walasek, M, Kramer, N, Maas, S, Maystadt, I, Mancini, G, McKee, S, Milunski, J, Miyake, N, Mizuno, S, Ohashi, H, Okamoto, N, Robertson, S, Soares, G, Tanabe, S, Vincent-Delorme, C, de Vries, B, Wieczorek, D & Wilson, L 2014, 'The ARID1B phenotype: What we have learned so far', American Journal of Medical Genetics, Part C: Seminars in Medical Genetics, vol. 166, no. 3, pp. 276-289. https://doi.org/10.1002/ajmg.c.31414
Santen, Gijs W E ; Clayton-Smith, Jill ; Adachi-Fukuda, Miho ; AlKindy, Adila ; Baban, Anwar ; Berry, Katherine ; Canham, Natalie ; Collins, Amanda ; Chrzanowska, Krystyna ; Gardham, Alice ; Horn, Denise ; Kato, Mitsuhiro ; Kosho, Tomoki ; Krajewska-Walasek, Malgorzata ; Kramer, Nancy ; Maas, Saskia ; Maystadt, Isabelle ; Mancini, Grazia ; McKee, Shane ; Milunski, Jeff ; Miyake, Noriko ; Mizuno, Seiji ; Ohashi, Hirofumi ; Okamoto, Nobuhiko ; Robertson, Stephen ; Soares, Gabriela ; Tanabe, Saori ; Vincent-Delorme, Catherine ; de Vries, Bert ; Wieczorek, Dagmar ; Wilson, Louise. / The ARID1B phenotype : What we have learned so far. In: American Journal of Medical Genetics, Part C: Seminars in Medical Genetics. 2014 ; Vol. 166, No. 3. pp. 276-289.
@article{dd56fa5de60f4764906b8e4c5bda5818,
title = "The ARID1B phenotype: What we have learned so far",
abstract = "Evidence is now accumulating from a number of sequencing studies that ARID1B not only appears to be one of the most frequently mutated intellectual disability (ID) genes, but that the range of phenotypes caused by ARID1B mutations seems to be extremely wide. Thus, it is one of the most interesting ID genes identified so far in the exome sequencing era. In this article, we review the literature surrounding ARID1B and attempt to delineate the ARID1B phenotype. The vast majority of published ARID1B patients have been ascertained through studies of Coffin-Siris syndrome (CSS), which leads to bias when documenting the frequencies of phenotypic features. Additional observations of those individuals ascertained through exome sequencing studies helps in delineation of the broader clinical phenotype. We are currently establishing an ARID1B consortium, aimed at collecting ARID1B patients identified through genome-wide sequencing strategies. We hope that this endeavor will eventually lead to a more comprehensive view of the ARID1B phenotype.",
keywords = "ARID1B, Coffin-siris syndrome, Review",
author = "Santen, {Gijs W E} and Jill Clayton-Smith and Miho Adachi-Fukuda and Adila AlKindy and Anwar Baban and Katherine Berry and Natalie Canham and Amanda Collins and Krystyna Chrzanowska and Alice Gardham and Denise Horn and Mitsuhiro Kato and Tomoki Kosho and Malgorzata Krajewska-Walasek and Nancy Kramer and Saskia Maas and Isabelle Maystadt and Grazia Mancini and Shane McKee and Jeff Milunski and Noriko Miyake and Seiji Mizuno and Hirofumi Ohashi and Nobuhiko Okamoto and Stephen Robertson and Gabriela Soares and Saori Tanabe and Catherine Vincent-Delorme and {de Vries}, Bert and Dagmar Wieczorek and Louise Wilson",
year = "2014",
doi = "10.1002/ajmg.c.31414",
language = "English",
volume = "166",
pages = "276--289",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - The ARID1B phenotype

T2 - What we have learned so far

AU - Santen, Gijs W E

AU - Clayton-Smith, Jill

AU - Adachi-Fukuda, Miho

AU - AlKindy, Adila

AU - Baban, Anwar

AU - Berry, Katherine

AU - Canham, Natalie

AU - Collins, Amanda

AU - Chrzanowska, Krystyna

AU - Gardham, Alice

AU - Horn, Denise

AU - Kato, Mitsuhiro

AU - Kosho, Tomoki

AU - Krajewska-Walasek, Malgorzata

AU - Kramer, Nancy

AU - Maas, Saskia

AU - Maystadt, Isabelle

AU - Mancini, Grazia

AU - McKee, Shane

AU - Milunski, Jeff

AU - Miyake, Noriko

AU - Mizuno, Seiji

AU - Ohashi, Hirofumi

AU - Okamoto, Nobuhiko

AU - Robertson, Stephen

AU - Soares, Gabriela

AU - Tanabe, Saori

AU - Vincent-Delorme, Catherine

AU - de Vries, Bert

AU - Wieczorek, Dagmar

AU - Wilson, Louise

PY - 2014

Y1 - 2014

N2 - Evidence is now accumulating from a number of sequencing studies that ARID1B not only appears to be one of the most frequently mutated intellectual disability (ID) genes, but that the range of phenotypes caused by ARID1B mutations seems to be extremely wide. Thus, it is one of the most interesting ID genes identified so far in the exome sequencing era. In this article, we review the literature surrounding ARID1B and attempt to delineate the ARID1B phenotype. The vast majority of published ARID1B patients have been ascertained through studies of Coffin-Siris syndrome (CSS), which leads to bias when documenting the frequencies of phenotypic features. Additional observations of those individuals ascertained through exome sequencing studies helps in delineation of the broader clinical phenotype. We are currently establishing an ARID1B consortium, aimed at collecting ARID1B patients identified through genome-wide sequencing strategies. We hope that this endeavor will eventually lead to a more comprehensive view of the ARID1B phenotype.

AB - Evidence is now accumulating from a number of sequencing studies that ARID1B not only appears to be one of the most frequently mutated intellectual disability (ID) genes, but that the range of phenotypes caused by ARID1B mutations seems to be extremely wide. Thus, it is one of the most interesting ID genes identified so far in the exome sequencing era. In this article, we review the literature surrounding ARID1B and attempt to delineate the ARID1B phenotype. The vast majority of published ARID1B patients have been ascertained through studies of Coffin-Siris syndrome (CSS), which leads to bias when documenting the frequencies of phenotypic features. Additional observations of those individuals ascertained through exome sequencing studies helps in delineation of the broader clinical phenotype. We are currently establishing an ARID1B consortium, aimed at collecting ARID1B patients identified through genome-wide sequencing strategies. We hope that this endeavor will eventually lead to a more comprehensive view of the ARID1B phenotype.

KW - ARID1B

KW - Coffin-siris syndrome

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=84908611305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908611305&partnerID=8YFLogxK

U2 - 10.1002/ajmg.c.31414

DO - 10.1002/ajmg.c.31414

M3 - Article

C2 - 25169814

AN - SCOPUS:84908611305

VL - 166

SP - 276

EP - 289

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 3

ER -